Large UK study tracks COVID-19's toll on MS patients

NCT ID NCT04354519

Completed Knowledge-focused Sponsor: Swansea University Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study follows thousands of people with multiple sclerosis (MS) in the UK to see how COVID-19 affects them. Researchers track infections, hospital stays, and deaths using questionnaires and national health data. The goal is to understand the risks and outcomes for this group, helping doctors and patients make informed decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal how COVID-19 affects people with MS, guiding better care and public health advice.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply outside the UK.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 MULTIPLE SCLEROSIS

Contacts and locations

Show contact details

Locations

Swansea Univeristy

Swansea, SA28PP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.